| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |